Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiota and its metabolites – molecular mechanisms and management strategies in diabetic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Dongwei Liu, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 22

Showing 22 citing articles:

TGF-β as A Master Regulator of Aging-Associated Tissue Fibrosis
Lili Ren, Hua Miao, Yanni Wang, et al.
Aging and Disease (2023) Vol. 14, Iss. 5, pp. 1633-1633
Open Access | Times Cited: 41
Ferroptosis: a potential bridge linking gut microbiota and chronic kidney disease
Zi‐Hui Mao, Zhong‐Xiuzi Gao, Shaokang Pan, et al.
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 5
Elucidating the causal relationship between gut microbiota, metabolites, and diabetic nephropathy in European patients: Revelations from genome-wide bidirectional mendelian randomization analysis
Siyuan Song, Ning Li, Jiangyi Yu
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Causal relationship between 412 gut microbiota, 1,400 blood metabolites, and diabetic nephropathy: a randomized Mendelian study
Binghao Cao, Caiyan Zhang, Zhen Wang, et al.
Frontiers in Endocrinology (2025) Vol. 15
Open Access
Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives
Jean Paule Joumaa, Angela Raffoul, Claudia Sarkis, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 3, pp. 727-727
Open Access
Therapeutic Strategies to Modulate Gut Microbial Health: Approaches for Chronic Metabolic Disorder Management
Mariangela Rondanelli, Sara Borromeo, Alessandro Cavioni, et al.
Metabolites (2025) Vol. 15, Iss. 2, pp. 127-127
Open Access
Machine-learning assisted discovery unveils novel interplay between gut microbiota and host metabolic disturbance in diabetic kidney disease
I‐Wen Wu, Yu-Chieh Liao, Tsung-Hsien Tsai, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access
Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
Daniela Maria Tănase, Evelina Maria Gosav, Tina Boţoc, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 18, pp. 6053-6053
Open Access | Times Cited: 11
Causal effect of gut microbiota and diabetic nephropathy: a Mendelian randomization study
Ganyuan He, Jiayi Chen, Wenke Hao, et al.
Diabetology & Metabolic Syndrome (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Feasible mechanisms and therapeutic potential of food probiotics to mitigate diabetes‐associated cancers: A comprehensive review and in silico validation
Annadurai Vinothkanna, Xiang Shi‐Liang, Durairaj Karthick Rajan, et al.
Food Frontiers (2024) Vol. 5, Iss. 4, pp. 1476-1511
Open Access | Times Cited: 2
A multi-omics approach to investigate characteristics of gut microbiota and metabolites in hypertension and diabetic nephropathy SPF rat models
Jinjing Lu, Xiaoying Gong, Chenlu Zhang, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 1
Analysis of the microecological mechanism of diabetic kidney disease based on the theory of “gut–kidney axis”: A systematic review
Lili Huang, Wenjing Wu, Xiaoqin Wang
Open Life Sciences (2024) Vol. 19, Iss. 1
Open Access | Times Cited: 1
Effects of Zhuang medicine compound Xiancao Granule on diabetic kidney disease: A multi-omics analysis
Chao Mo, Jie Zhao, Jingyan Liang, et al.
Journal of Ethnopharmacology (2023) Vol. 321, pp. 117517-117517
Closed Access | Times Cited: 3
Unravelling the Crosstalk between Estrogen Deficiency and Gut-biota Dysbiosis in the Development of Diabetes Mellitus
Rishabh, Seema Bansal, Akriti Goel, et al.
Current Diabetes Reviews (2024) Vol. 20, Iss. 10
Closed Access
Research Progress in the Treatment of Diabetic Nephropathy Based on Intestinal Microecology
新建 纪
Hans Journal of Biomedicine (2024) Vol. 14, Iss. 01, pp. 81-89
Closed Access
Gut Microbiota-derived Metabolites: A New Perspective of Traditional Chinese Medicine Against Diabetic Kidney Disease
Hailing Zhao, Tingting Zhao, Ping Li
Integrative Medicine in Nephrology and Andrology (2024) Vol. 11, Iss. 2
Closed Access
Research progress on Alpinia oxyphylla in the treatment of diabetic nephropathy
Jing Wang, Xiaomin Wang, Tianpeng Ma, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access
The potential mediating role of the gut microbiome and metabolites in the association between PFAS and kidney function in young adults: A proof-of-concept study
Hailey Hampson, Shiwen Li, Douglas I. Walker, et al.
The Science of The Total Environment (2024), pp. 176519-176519
Closed Access
Epidemiological characteristics, complications of haemodialysis patients with end-stage diabetic nephropathy in a tertiary hospital in Guizhou, China: a cross-sectional survey
Xiuping Xu, Nengyuan Yang, Jingjing Da, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access
Causal Relationships Between Gut Microbiota, Metabolites, and Diabetic Nephropathy: Insights from a Two-Sample Mendelian Randomization Analysis
Xixi Song, Jingqiu Cui, Shiwei Li, et al.
International Journal of Nephrology and Renovascular Disease (2024) Vol. Volume 17, pp. 319-332
Open Access
Clinical significance of uremic toxin indoxyl sulfate and inflammation in the development of vascular calcification and cardiovascular complications in stage C3–C5D chronic kidney disease
Ф. У. Дзгоева, О. В. Ремизов, V. G. Goloeva, et al.
Terapevticheskii arkhiv (2023) Vol. 95, Iss. 6, pp. 468-474
Open Access | Times Cited: 1
The Abnormal Accumulation of Lipopolysaccharide Secreted by Enriched Gram-Negative Bacteria Increases the Risk of Rotavirus Colonization in Young Adults
Yifan Wu, Shuang Pei, Jie Wu, et al.
Microorganisms (2023) Vol. 11, Iss. 9, pp. 2280-2280
Open Access | Times Cited: 1
Study of the influence of GLP-1 receptor agonists on the metabolic activity of the intestinal microbiota in patients with type 2 DM
О.В. Zinych, Yuriy Stepanov, К.О. Shyshkan-Shyshova, et al.
ScienceRise Medical Science (2023), Iss. 6 (57), pp. 24-30
Open Access
Page 1

Scroll to top